Symbol
| SPH1
|
Location
| 8p11.21
|
Name
|
hereditary spherocytosis, type II |
Corresponding gene
|
ANK1
|
Other symbol(s)
| HS
|
Main clinical features
|
haemolytic anemia of variable severity, moderate in ~60 percent of cases, severe life-threatening anemia in 3-5 percent
prominent spherocytosis |
Genetic determination
| autosomal dominant |
| autosomal recessive |
Function/system disorder
| hematology |
Type
| disease
|
Name
| ankyrin, erythroid (ANK1), links beta-spectrin to band 3
|
Gene mutation | Chromosome rearrangement | Effect | Comments |
|
---|
deletion
|  
|  
| in the promoter altering gene expression, transcription initiation and TF2D complex formation
| various types
|  
|  
|  
| |
Remark(s)
|
Ankyrin defect in 50-60 percent of HS cases innorthern european populations, and in 5-10 percent in japan |